- Home
- XENE vs HWKN Comparison
XENE vs HWKN Comparison
Compare XENE & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- HWKN
- Stock Information
- Founded
- XENE 1996
- HWKN 1938
- Country
- XENE Canada
- HWKN United States
- Employees
- XENE N/A
- HWKN N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- HWKN Specialty Chemicals
- Sector
- XENE Health Care
- HWKN Consumer Discretionary
- Exchange
- XENE Nasdaq
- HWKN Nasdaq
- Market Cap
- XENE 2.4B
- HWKN 2.9B
- IPO Year
- XENE 2014
- HWKN N/A
- Fundamental
- Price
- XENE $32.21
- HWKN $155.30
- Analyst Decision
- XENE Strong Buy
- HWKN Strong Buy
- Analyst Count
- XENE 11
- HWKN 1
- Target Price
- XENE $54.82
- HWKN $160.00
- AVG Volume (30 Days)
- XENE 1.5M
- HWKN 209.7K
- Earning Date
- XENE 08-07-2025
- HWKN 07-30-2025
- Dividend Yield
- XENE N/A
- HWKN 0.46%
- EPS Growth
- XENE N/A
- HWKN 12.26
- EPS
- XENE N/A
- HWKN 4.03
- Revenue
- XENE $7,500,000.00
- HWKN $974,431,000.00
- Revenue This Year
- XENE N/A
- HWKN $12.68
- Revenue Next Year
- XENE $253.71
- HWKN $4.01
- P/E Ratio
- XENE N/A
- HWKN $38.54
- Revenue Growth
- XENE N/A
- HWKN 6.01
- 52 Week Low
- XENE $26.74
- HWKN $93.50
- 52 Week High
- XENE $46.00
- HWKN $156.61
- Technical
- Relative Strength Index (RSI)
- XENE 50.43
- HWKN 78.11
- Support Level
- XENE $31.22
- HWKN $139.00
- Resistance Level
- XENE $33.51
- HWKN $156.61
- Average True Range (ATR)
- XENE 1.24
- HWKN 4.49
- MACD
- XENE 0.06
- HWKN 0.88
- Stochastic Oscillator
- XENE 40.88
- HWKN 93.09
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About HWKN Hawkins Inc.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.